Loss of heterozygosity, aberrant methylation, BRAF mutation and KRAS mutation in colorectal signet ring cell carcinoma

被引:44
|
作者
Kakar, Sanjay [1 ,2 ,3 ]
Deng, Guoren [3 ]
Smyrk, Thomas C. [4 ]
Cun, Lisa [3 ]
Sahai, Vaibhav [5 ]
Kim, Young S. [3 ]
机构
[1] UCSF, VA Med Ctr, Dept Anat Pathol, San Francisco, CA 94121 USA
[2] Vet Affairs Med Ctr, Dept Pathol, San Francisco, CA 94121 USA
[3] Vet Affairs Med Ctr, Gastrointestinal Res Lab, San Francisco, CA 94121 USA
[4] Mayo Clin, Dept Pathol, Rochester, MN USA
[5] Northwestern Univ, Dept Hematol Oncol, Chicago, IL 60611 USA
关键词
BRAF; KRAS; LOH; methylation; signet ring; CPG ISLAND METHYLATION; COMPARATIVE GENOMIC HYBRIDIZATION; MICROSATELLITE INSTABILITY; CLINICOPATHOLOGICAL FEATURES; COLON-CANCER; TRADITIONAL ADENOMAS; MOLECULAR-FEATURES; DNA METHYLATION; PHENOTYPE; ADENOCARCINOMA;
D O I
10.1038/modpathol.2012.44
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The relationship of molecular abnormalities with clinicopathologic features and survival in colorectal signet ring cell carcinoma, and its comparison with mucinous and conventional adenocarcinomas, has not been well studied. High-level microsatellite instability, loss of heterozygosity (LOH) at four loci, CpG island methylation phenotype based on seven loci, BRAF V600E mutation and KRAS mutation in signet ring cell carcinoma were compared with mucinous and conventional adenocarcinomas. The relationship of these molecular features in signet ring cell carcinoma with clinicopathologic features and survival was examined. LOH was observed in 93% of signet ring cell carcinomas compared with 62 and 70% of mucinous and conventional adenocarcinomas. Also, 80% of signet ring cell carcinomas with high-level microsatellite instability showed LOH compared with 14% each of mucinous and conventional adenocarcinomas. High-level microsatellite instability, CpG island methylation phenotype-positive status and BRAF V600E mutation were more often seen in signet ring cell carcinoma and mucinous adenocarcinoma compared with conventional adenocarcinoma. BRAF V600E mutation was significantly associated with CpG island methylation phenotype-positive status. Stage and BRAF V600E mutation in microsatellite-stable cases were the only variables with an affect on survival. In conclusion, chromosomal instability manifested by LOH is nearly a universal finding in signet ring cell carcinoma, including cases with high-level microsatellite instability. This may explain the aggressive behavior of signet ring cell carcinoma irrespective of high-level microsatellite-instability status. BRAF V600E mutation and CpG island methylation phenotype-positive status are similar in signet ring cell carcinoma and mucinous adenocarcinoma but more frequent when compared with conventional adenocarcinoma. In signet ring cell carcinoma, BRAF V600E mutation adversely affects survival in microsatellite-stable tumors, but not in high-level microsatellite-unstable tumors. The high frequency of methylation and BRAF V600E mutation suggests that many signet ring cell carcinomas may be related to the serrated pathway of carcinogenesis. Modern Pathology (2012) 25, 1040-1047; doi: 10.1038/modpathol.2012.44; published online 20 April 2012
引用
收藏
页码:1040 / 1047
页数:8
相关论文
共 50 条
  • [1] BRAF mutation in colorectal carcinomas with signet ring cell component
    Serap Yalcin
    Onder Onguru
    [J]. Cancer Biology & Medicine, 2017, (03) : 287 - 292
  • [2] BRAF mutation in colorectal carcinomas with signet ring cell component
    Yalcin, Serap
    Onguru, Onder
    [J]. CANCER BIOLOGY & MEDICINE, 2017, 14 (03) : 287 - 292
  • [3] BRAF mutation in colorectal carcinomas with signet ring cell component
    Serap Yalcin
    Onder Onguru
    [J]. Cancer Biology & Medicine., 2017, 14 (03) - 292
  • [4] BRAF mutation in colorectal carcinomas with signet ring cell component
    Onguru, O.
    Yalcin, S.
    Altayli, E.
    Ozturk, M.
    Ersoz, N.
    [J]. VIRCHOWS ARCHIV, 2012, 461 : S185 - S185
  • [5] Loss of heterozygosity and aberrant methylation in signet ring cell colorectal cancer: correlation with clinicopathologic features and survival
    Kakar, S.
    Deng, G.
    Cun, L.
    Kim, Y.
    [J]. HISTOPATHOLOGY, 2008, 53 : 140 - 141
  • [6] Aberrant CpG island methylation, BRAF/KRAS mutation, microsatellite instability, and genotypes of MTHFR in colorectal carcinomas and their relationships
    Lee, S
    Cho, NY
    Kang, GH
    [J]. MODERN PATHOLOGY, 2006, 19 : 112A - 112A
  • [7] Aberrant CpG island methylation, BRAF/KRAS mutation, microsatellite instability, and genotypes of MTHFR in colorectal carcinomas and their relationships
    Lee, S
    Cho, NY
    Kang, GH
    [J]. LABORATORY INVESTIGATION, 2006, 86 : 112A - 112A
  • [8] Lack of KRAS and BRAF Mutation in Renal Cell Carcinoma
    Gattenloehner, S.
    Etschmann, B.
    Riedmiller, H.
    Mueller-Hermelink, H.-K.
    [J]. EUROPEAN UROLOGY, 2009, 55 (06) : 1490 - 1491
  • [9] PTEN mutation, loss of heterozygosity, promoter methylation and expression in colorectal carcinoma: Two hits on the gene?
    Huehns, Maja
    Salem, Tareq
    Schneider, Bjoern
    Krohn, Mathias
    Linnebacher, Michael
    Prall, Friedrich
    [J]. ONCOLOGY REPORTS, 2014, 31 (05) : 2236 - 2244
  • [10] Loss of CDX1 expression in colorectal carcinoma: Promoter methylation, mutation, and loss of heterozygosity analyses of 37 cell lines
    Wong, NACS
    Britton, MP
    Choi, GS
    Stanton, TK
    Bicknell, DC
    Wilding, JL
    Bodmer, WF
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (02) : 574 - 579